Conference
Real-world outcomes among patients with advanced/metastatic renal cell carcinoma (mRCC) treated with cabozantinib or other tyrosine kinase inhibitors (TKIs) after checkpoint inhibitor (CPI) therapy.
Authors
Heng DYC; Doshi GK; Dutailly P; Houchard A; Lothgren M; Monnette A; Wang Y; Perrot V; Lalani A-KA
Volume
41
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2023
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
IL, Chicago
Conference start date
June 2, 2023
Conference end date
June 6, 2023
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X